Press release
American Bio Medica Corporation (ABMC) - Product Pipeline Analysis, 2016 Report
American Bio Medica Corporation (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The companys products include Rapid TOX, a point of collection testing (POCT) product that detects 1-10 drugs of abuse (DOA) in a urine specimen; Rapid One, a test cassette which is designed to detect a single DOA in a urine specimen; Rapid Drug Screen, detects 2 to 10 DOA in a single urine specimen; OralStat, used for the detection of DOA in oral fluids; and others. It also provides provide bulk test strip contract manufacturing services. ABMC serves various markets including government, education, rehabilitation and drug treatment, and others. The company distributes its products directly and also through a network of distributors worldwide. ABMC is headquartered in Kinderhook, New York, the US.This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company American Bio Medica Corporation
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release American Bio Medica Corporation (ABMC) - Product Pipeline Analysis, 2016 Report here
News-ID: 354755 • Views: …
More Releases for DOA
Key Influencer in the Drugs of Abuse (DOA) Testing Market 2025: Rising Demand Fo …
What combination of drivers is leading to accelerated growth in the drugs of abuse (doa) testing market?
The expected rise in demand for treatment of drug abuse is predicted to spur the growth of the drugs of abuse (DOA) testing market. The term drug or substance abuse pertains to the injurious use of substances in quantities harmful to the user and others. Drug testing is a means to detect unnatural compounds…
Global At-Home Drug of Abuse (DOA) Testing Market Imapct of AI and Automation
At-Home Drug of Abuse (DOA) Testing Market Impact of AI and Automation
In 2022, the At-Home Drug of Abuse (DOA) Testing market was valued at approximately USD 1.2 billion, with an anticipated compound annual growth rate (CAGR) of 7.5% projected through 2027. This growth reflects increasing consumer demand for privacy and convenience in drug testing solutions, driven by rising awareness of substance abuse and stringent regulations. The market's expansion is supported…
Dioctyl Adipate (DOA) Market Analysis and Future Prospects for 2030
The world of the dioctyl adipate (doa) market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing…
Drugs of Abuse (DOA) Testing Market is Growing at CAGR of 10.25% by 2030
A worldwide Drugs of Abuse (DOA) Testing market report is the best to know the trends and opportunities in Healthcare industry. The forecast, analysis, evaluations and estimations carried out in this business report are all based upon the well established tools and techniques such as SWOT analysis and Porter's Five Forces analysis. These are the authentic tools used in market analysis on which businesses can trust confidently. The credible Drugs…
At-Home DOA Testing Market : Business Overview and Global Development Trends
Global At-Home DOA Testing Market: Overview
Developing unlawful medications use among young people, rising number of initiatives by the administration organizations to lessen the medication misuse levels, and expanded creation of engineered cannabinoids, bath salts, and other rising medications are boosting the interest for at-home DOA testing items in the market.
A report by Transparency Market Research (TMR) on the global at-home DOA testing market market is an adroit explanation…
DOA Testing Market Size, Leaders, Segment Analysis and Forecast Report 2023
The increasing adoption of drug of abuse (DOA) testing at the organizational level, growing number of road accidents and deaths, and rising consumption of illicit drugs are some of the reasons behind the growth of the DOA testing market. In 2016, the market generated a revenue of $4.8 billion, and it is predicted to advance at a CAGR of 9.6% during the forecast period (2017–2023). Drug testing refers to the…